An analysis method for influenza virus particles has been developed using SEC which provides complimentary biopharmaceutical data for use during vaccine production and approval.
Photo Credit: dottedyeti/stock.adoboe.com
An analysis method for influenza virus particles has been developed using size-exclusion chromatography (SEC) which provides complimentary biopharmaceutical data for use during vaccine production and approval (1).
Vaccination is the most effective form of influenza control, preventing widescale outbreaks and pandemics from emerging. Various manufacturers produce influenza vaccines utilizing inactivated whole virus particles to illicit an immune response in the recipient via the surface antigens present on the viruses. Primarily these are Hemagglutinin (HA) and neuraminidase (N) with 17 different HA and 10 different neuraminidases being identified. As such, the amount of HA in any produced vaccine is crucial to the effectiveness and subsequent release of a vaccine for use with various guidelines existing to ensure enough HA antigen is present.
Currently, HA quantification mostly relies on two methods: the single radial immunodiffusion (SRID) assay and the HA assay. SRID is considered the gold standard and is based on antigen binding, whereas HA assays use the hemagglutination of erythrocytes. Despite its history, widespread acceptance, and various uses, the HA assay has a number of drawbacks such as the lack of standardization, its discrete format, deviations due to erythrocyte aging (2), secondary interactions of pH, buffer ions (3), and other compounds in complex virus samples. These drawbacks have become particularly relevant in recent years as authoritative bodies have sought an enhanced understanding and control of the vaccine production process with investigation of size, content, and immunogenicity of aggregates in the drug product or substance recommended. As such, numerous techniques and methods have been published offering solutions.
One such publication focused on analytical size-exclusion chromatography (SEC), a non-destructive technique that has been used for decades to analyze the aggregate and fragment content of therapeutic proteins (4). Researchers developed a robust method that handles different buffer systems, ionic strength, and additive concentrations well. Requiring the addition of 200-mM arginine or sodium chloride to obtain complete virus particle recovery. The results are confirmed by dynamic light scattering (DLS), and the universal applicability of the method was demonstrated with three different influenza virus samples, including the pandemic H1N1 vaccine strain 5258 which is an industrially-produced pandemic vaccine strain. The method adds valuable data regarding the size distribution of influenza virus samples to the commonly- used HA assay for the quantification of influenza viruses, and can potentially be used to adhere to ever stricter guidelines from biopharmaceutical regulatory bodies.
References
Unlocking Metabolic Mysteries: Glioma Tumor Spheroids' Biochemical Blueprint Revealed
March 18th 2024In a recent study, researchers from the Chinese Academy of Medical Sciences and Peking Union Medical College used liquid chromatography–mass spectrometry (LC–MS) to gain further insight into tumor metabolism.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.